Tachykinins and tachykinin receptors in human uterus
Open Access
- 1 June 2003
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 139 (3), 523-532
- https://doi.org/10.1038/sj.bjp.0705279
Abstract
Studies were undertaken to determine the nature of the receptors mediating contractile effects of tachykinins in the uteri of nonpregnant women, and to analyse the expression of preprotachykinins (PPT), tachykinin receptors and the cell‐surface peptidase, neprilysin (NEP), in the myometrium from pregnant and nonpregnant women. The neurokinin B (NKB) precursor PPT‐B was expressed in higher levels in the myometrium from nonpregnant than from pregnant women. Faint expression of PPT‐A mRNA was detectable in the myometrium from nonpregnant but not pregnant women. PPT‐C, the gene encoding the novel tachykinin peptide hemokinin‐1 (HK‐1), was present in trace amounts in the uteri from both pregnant and nonpregnant women. Tachykinin NK2 receptors were more strongly expressed in tissues from nonpregnant than from pregnant women. NK1 receptor mRNA was present in low levels in tissues from both pregnant and nonpregnant women. A low abundance transcript corresponding to the NK3 receptor was present only in tissues from nonpregnant women. The mRNA expression of the tachykinin‐degrading enzyme NEP was lower in tissues from nonpregnant than from pregnant women. Substance P (SP), neurokinin A (NKA) and NKB, in the presence of the peptidase inhibitors thiorphan, captopril and bestatin, produced contractions of myometrium from nonpregnant women. The order of potency was NKA≫SP≥NKB. The potency of NKA was unchanged in the absence of peptidase inhibitors. The tachykinin NK2 receptor‐selective agonist [Lys5MeLeu9Nle10]NKA(4–l0) was approximately equipotent with NKA, but the tachykinin NK1 and NK3 receptor‐selective agonists [Sar9Met(O2)11]SP and [MePhe7]NKB were ineffective in the myometrium from nonpregnant women. The uterotonic effects of [Lys5MeLeu9Nle10]NKA(4–10) were antagonized by the tachykinin NK2 receptor‐selective antagonist SR48968. Neither atropine, nor phentolamine nor tetrodotoxin affected responses to [Lys5MeLeu9Nle10]NKA(4–10). These data are consistent with a role of tachykinins in the regulation of human uterine function, and reinforce the importance of NK2 receptors in the regulation of myometrial contraction. British Journal of Pharmacology (2003) 139, 523–532. doi:10.1038/sj.bjp.0705279This publication has 152 references indexed in Scilit:
- Pelvic nerve plexus trauma at radical and simple hysterectomy: a quantitative study of nerve types in the uterine supporting ligamentsJournal of the Society for Gynecologic Investigation, 2002
- Stress Triggered Abortions Are Associated With Alterations of Granulated Cells in the DeciduaAmerican Journal of Reproductive Immunology, 1997
- Neurokinin receptor subtypes characterized by biological assaysLife Sciences, 1994
- Cellular localization of membrane metalloendopeptidase (enkephalinase) in human endometrium during the ovarian cycleJournal of Clinical Endocrinology & Metabolism, 1993
- A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptorLife Sciences, 1992
- Molecular cloning, structural characterization and functional expression of the human substance P receptorBiochemical and Biophysical Research Communications, 1991
- The sensory-efferent function of capsaicin-sensitive sensory neuronsGeneral Pharmacology: The Vascular System, 1988
- cDNA sequence of human β-preprotachykinin, the common precursor to substance P and neurokinin AFEBS Letters, 1986
- Neurokinin B is hydrolysed by synaptic membranes and by endopeptidase‐24.11 (‘enkephalinase’) but not by angiotensin converting enzymeFEBS Letters, 1985
- Neuropeptides in the Regulation of Female Genital Smooth Muscle ContractilityActa Obstetricia et Gynecologica Scandinavica, 1983